Skip to content

Could mainstream molecular testing hold the key to unlocking the flu challenge?

As we enter the winter flu season, embracing more innovative diagnostics at the point of care (POC) could play a vital role in helping to address the burden which influenza places on public health services.

Could mainstream molecular testing hold the key to unlocking the flu challenge?
Published: | 3 min read

As we enter the winter flu season, embracing more innovative diagnostics at the point of care (POC) could play a vital role in helping to address the burden which influenza places on public health services, David Fraser, lateral flow product manager, BBI Solutions writes. 

Flu

With last year’s flu season one of the worst on record - investment and innovation in how we test for, monitor, and treat flu is key.

Sign up to our newsletter

The week's biggest stories from this industry, direct to your inbox.

Personal information